Translation Services for Medical Device Manufacturers

Medical device manufacturers typically need translation services covering IFUs, labelling, eIFUs, implant cards, safety warnings, Field Safety Notices, vigilance and FSCA communications, technical documentation, regulatory submissions, clinical evaluation reports, PMS and PMCF content, UDI and EUDAMED content, medical device software UI, QMS documentation, SOPs, training materials, websites and marketing content. Translation is needed across many languages depending on target markets, and across many device classes and lifecycle stages. The objective is accurate, complete and source-faithful translation supported by qualified linguists, controlled terminology, traceable workflows and review steps proportionate to the content risk.

Translation requests inside a medical device manufacturer are typically managed or initiated by QARA Managers, PRRCs, Documentation Managers, Clinical Affairs Managers, Regulatory Affairs Managers, Localization Managers and Product Managers. Software, marketing, training and distributor teams also generate translation needs. In many organisations, translation responsibility is spread across departments, which can lead to inconsistent terminology, duplicated suppliers and weaker traceability. A consolidated approach with a specialised partner helps centralise multilingual content, align terminology and provide consistent evidence across IFUs, labelling, software, technical files and regulatory submissions.

An MDR translation partner is a specialised language services provider that supports medical device manufacturers with multilingual content within the framework of Regulation (EU) 2017/745. This typically includes translation of IFUs, labelling, eIFUs, implant cards, technical files, clinical evaluation content, PMS and PMCF documentation, software UI and regulatory submissions, with attention to MDR terminology, target country language requirements and EU medical device labeling language requirements. An MDR translation partner supports manufacturers but does not replace MDR compliance assessment, notified body decisions or competent authority approval, which remain with the manufacturer and its qualified internal and external advisers.

MDR language requirements refer to the languages in which medical device information, IFUs, labelling and related documentation must be made available depending on the member states where the device is placed on the market. Specific requirements vary by country and content type, with EU medical device labeling language requirements driven by Regulation (EU) 2017/745 and national rules. AbroadLink supports multilingual planning aligned with these requirements through specialised translation services for medical device manufacturers, but final compliance assessment, language selection and content approval remain with the manufacturer and its qualified regulatory advisers in each market.

Terminology control is important because medical device content repeats across many documents and languages, including IFUs, labelling, eIFUs, technical files, software UI, clinical documentation, PMS content, training materials and marketing. Inconsistent terminology across these assets can confuse users, create audit findings, generate rework during MDR or IVDR reviews and slow down market launches. Validated glossaries, translation memories, MDR and IVDR terminology references and reusable controlled content help manufacturers keep multilingual content aligned across departments, suppliers, devices and lifecycle stages, supporting consistency that fits into the quality management system and regulated documentation.

No. The objective of every workflow is accurate, complete and source-faithful translation. What changes is the workflow used to manage the risk of not achieving that objective, the review depth, the cost and the turnaround. Lower-risk workflows may be appropriate for internal drafts, administrative documents, repeated content, distributor support material or low-impact updates when internal controls support that decision. They are different processes for managing translation risk, not lower accuracy requirements. Higher-risk content such as IFUs, labelling, safety warnings, technical documentation, clinical documentation and regulatory submissions typically follows more robust workflows with independent revision.

No. Translation services for medical device manufacturers help you produce accurate, traceable multilingual content aligned to your approved source, but they do not guarantee MDR compliance, IVDR compliance, FDA compliance, notified body acceptance, competent authority acceptance, audit acceptance, product approval, CE marking, safe use, correct use, software validation, usability validation or market access. Regulatory strategy, MDR planning, IVDR planning, PRRC responsibility, clinical evaluation, quality decisions and final content approval remain with the manufacturer and its qualified internal and external advisers. AbroadLink acts as a specialised language partner supporting your existing processes.

CertLink is AbroadLink's portal for accessing translation certificates linked to your projects. Each certificate is signed and includes the project code, languages, documents, linguists involved and, where relevant, information about controlled AI use during pre-translation. For medical device manufacturers, CertLink provides a centralised, searchable place to retrieve evidence of translation work across departments, devices and markets, which can support notified body audits, competent authority questions, distributor due diligence and internal QMS reviews. It complements, but does not replace, your internal translation procedures, regulatory documentation and quality records, which remain under your responsibility.